In a filing, Adverum Biotechnologies Inc revealed its Director Lupher, Jr. Mark L. acquired Company’s shares for reported $0.18 million on Feb 07 ’24. In the deal valued at $1.35 per share,130,000 shares were bought. As a result of this transaction, Lupher, Jr. Mark L. now holds 130,000 shares worth roughly $1.56 million.
Then, Scopa James Paul bought 100,000 shares, generating $135,000 in total proceeds. Upon buying the shares at $1.35, the Director now owns 100,000 shares.
Before that, Seyedkazemi Setareh sold 6,201 shares. Adverum Biotechnologies Inc shares valued at $9,429 were divested by the Chief Development Officer at a price of $1.52 per share. As a result of the transaction, Seyedkazemi Setareh now holds 47,674 shares, worth roughly $0.57 million.
Truist upgraded its Adverum Biotechnologies Inc [ADVM] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who decreased its forecast for the stock in late July from “an Overweight” to “a Neutral”. SVB Leerink also remained covering ADVM and has decreased its forecast on May 03, 2021 with a “Mkt perform” recommendation from previously “an Outperform” rating. Truist revised its rating on April 29, 2021. It rated ADVM as “a Hold” which previously was an “a Buy”.
Price Performance Review of ADVM
On Tuesday, Adverum Biotechnologies Inc [NASDAQ:ADVM] saw its stock fall -4.53% to $12.01. Over the last five days, the stock has lost -10.37%. Adverum Biotechnologies Inc shares have risen nearly 59.54% since the year began. Nevertheless, the stocks have risen 76.36% over the past one year. While a 52-week high of $29.70 was reached on 02/08/24, a 52-week low of $6.81 was recorded on 01/02/24. SMA at 50 days reached $17.25, while 200 days put it at $14.07. A total of 0.51 million shares were traded, compared to the trading of 0.17 million shares in the previous session.
Levels Of Support And Resistance For ADVM Stock
The 24-hour chart illustrates a support level at 11.68, which if violated will result in even more drops to 11.35. On the upside, there is a resistance level at 12.53. A further resistance level may holdings at 13.05. The Relative Strength Index (RSI) on the 14-day chart is 30.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.52, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.58%. Stochastics %K at 2.53% indicates the stock is a buying.
How much short interest is there in Adverum Biotechnologies Inc?
A steep rise in short interest was recorded in Adverum Biotechnologies Inc stocks on Mar 15, 2024, growing by 0.25 million shares to a total of 0.65 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 0.4 million shares. There was a rise of 38.17%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 3.25% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.39.
